TW202239762A - 桿狀病毒表現系統 - Google Patents

桿狀病毒表現系統 Download PDF

Info

Publication number
TW202239762A
TW202239762A TW110121552A TW110121552A TW202239762A TW 202239762 A TW202239762 A TW 202239762A TW 110121552 A TW110121552 A TW 110121552A TW 110121552 A TW110121552 A TW 110121552A TW 202239762 A TW202239762 A TW 202239762A
Authority
TW
Taiwan
Prior art keywords
orf1
nucleic acid
molecule
sequence
genetic element
Prior art date
Application number
TW110121552A
Other languages
English (en)
Chinese (zh)
Inventor
賽門 德拉葛瑞夫
傑拉德 大衛 皮滋
Original Assignee
美商旗艦先鋒創新公司
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 美商旗艦先鋒創新公司 filed Critical 美商旗艦先鋒創新公司
Publication of TW202239762A publication Critical patent/TW202239762A/zh

Links

Images

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • C12N15/86—Viral vectors
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/14011—Baculoviridae
    • C12N2710/14041—Use of virus, viral particle or viral elements as a vector
    • C12N2710/14043—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vectore
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/14011—Baculoviridae
    • C12N2710/14041—Use of virus, viral particle or viral elements as a vector
    • C12N2710/14044—Chimeric viral vector comprising heterologous viral elements for production of another viral vector
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2750/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssDNA viruses
    • C12N2750/00011—Details
    • C12N2750/00022—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2750/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssDNA viruses
    • C12N2750/00011—Details
    • C12N2750/00041—Use of virus, viral particle or viral elements as a vector
    • C12N2750/00043—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Biomedical Technology (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Virology (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Microbiology (AREA)
  • Plant Pathology (AREA)
  • Physics & Mathematics (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
TW110121552A 2020-06-12 2021-06-11 桿狀病毒表現系統 TW202239762A (zh)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US202063038603P 2020-06-12 2020-06-12
US63/038,603 2020-06-12
US202163147056P 2021-02-08 2021-02-08
US63/147,056 2021-02-08

Publications (1)

Publication Number Publication Date
TW202239762A true TW202239762A (zh) 2022-10-16

Family

ID=78845950

Family Applications (1)

Application Number Title Priority Date Filing Date
TW110121552A TW202239762A (zh) 2020-06-12 2021-06-11 桿狀病毒表現系統

Country Status (12)

Country Link
US (1) US20230340527A1 (cg-RX-API-DMAC10.html)
EP (1) EP4164667A4 (cg-RX-API-DMAC10.html)
JP (1) JP2023530277A (cg-RX-API-DMAC10.html)
KR (1) KR20230036109A (cg-RX-API-DMAC10.html)
CN (1) CN116034160A (cg-RX-API-DMAC10.html)
AU (1) AU2021288051A1 (cg-RX-API-DMAC10.html)
BR (1) BR112022025221A2 (cg-RX-API-DMAC10.html)
CA (1) CA3186872A1 (cg-RX-API-DMAC10.html)
IL (1) IL298906A (cg-RX-API-DMAC10.html)
MX (1) MX2022015801A (cg-RX-API-DMAC10.html)
TW (1) TW202239762A (cg-RX-API-DMAC10.html)
WO (1) WO2021252943A2 (cg-RX-API-DMAC10.html)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA3121528A1 (en) 2018-12-12 2020-06-18 Flagship Pioneering Innovations V, Inc. Anellosomes and methods of use
CA3206361A1 (en) * 2020-12-23 2022-06-30 Flagship Pioneering Innovations V, Inc. In vitro assembly of anellovirus capsids enclosing rna
WO2022170195A1 (en) * 2021-02-08 2022-08-11 Flagship Pioneering Innovations V, Inc. Hybrid aav-anellovectors
TW202334423A (zh) 2021-12-15 2023-09-01 美商旗艦先鋒創新公司 表面經修飾之病毒顆粒及模組化之病毒顆粒
TW202529819A (zh) 2023-10-13 2025-08-01 美商旗艦先鋒創新公司 組織特異性指環載體(anellovector)遞送
CN117305365B (zh) * 2023-11-28 2024-03-19 中国科学院生物物理研究所 昆虫细胞—哺乳动物细胞表达穿梭载体SmartBM-1及其应用
WO2025160409A1 (en) 2024-01-26 2025-07-31 Flagship Pioneering Innovations V, Inc. Viral vectors for modulating vegf function

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2011046634A1 (en) * 2009-10-16 2011-04-21 Pfizer, Inc. Infectious clones of torque teno virus
KR101320192B1 (ko) * 2008-10-16 2013-10-30 조에티스 엘엘씨 토크 테노 바이러스(ttv) 분리물 및 조성물
RU2553223C2 (ru) * 2009-08-21 2015-06-10 Виргиния Тек Интеллекчуал Пропертиз, Инк. ВАКЦИНЫ НА ОСНОВЕ СВИНОГО ВИРУСА Torque teNO И СПОСОБЫ ДИАГНОСТИКИ ИНФЕКЦИЙ, ВЫЗВАННЫХ ЭТИМ ВИРУСОМ
CA3066750A1 (en) * 2017-06-13 2018-12-20 Flagship Pioneering Innovations V, Inc. Compositions comprising curons and uses thereof

Also Published As

Publication number Publication date
CN116034160A (zh) 2023-04-28
CA3186872A1 (en) 2021-12-16
EP4164667A2 (en) 2023-04-19
WO2021252943A3 (en) 2022-01-20
BR112022025221A2 (pt) 2023-03-07
KR20230036109A (ko) 2023-03-14
EP4164667A4 (en) 2024-10-23
JP2023530277A (ja) 2023-07-14
IL298906A (en) 2023-02-01
AU2021288051A1 (en) 2023-01-19
US20230340527A1 (en) 2023-10-26
WO2021252943A2 (en) 2021-12-16
MX2022015801A (es) 2023-05-19

Similar Documents

Publication Publication Date Title
US20260009050A1 (en) Anellosomes for delivering secreted therapeutic modalities
US20230340527A1 (en) Baculovirus expression systems
US20220073950A1 (en) Anellosomes for delivering protein replacement therapeutic modalities
KR20210131310A (ko) 아넬로좀 및 사용 방법
US20230348933A1 (en) Tandem anellovirus constructs
US20230227849A1 (en) Methods of identifying and characterizing anelloviruses and uses thereof
US20240254512A1 (en) Anellovectors and methods of use
US20250257368A1 (en) In vitro assembly of anellovirus capsids enclosing rna
US20240000914A1 (en) Chicken anemia virus (cav)-based vectors
US20240123083A1 (en) Hybrid aav-anellovectors
US12540337B2 (en) Surface-modified viral particles and modular viral particles
TW202417632A (zh) 新穎指環病毒科(anelloviridae)載體組合物及方法
TW202334431A (zh) 新穎指環載體(anellovector)組合物及方法